Citigroup Inc. downgraded Swiss Re AG – ADR (NASDAQ:SSREY) to Sell in a statement released earlier today.
- Updated: September 17, 2016
Displaying a price of $20.91, Swiss Re AG – ADR (NASDAQ:SSREY) traded 1.69% lower on the day. The last stock price close is down 2.36% relative to the two hundred day moving average, compared with the Standard & Poor’s 500 Index which has decreased -0.01% over the same time period. Swiss Re AG – ADR has registered a 50-day moving average of $21.20 and 200-day moving average of $22.01. 149,398 shares of Swiss Re AG – ADR exchanged hands, up from ann average volume of 56,856
Citigroup Inc. has downgraded Swiss Re AG – ADR(NASDAQ:SSREY) to Sell in a report released 8/18/2016.
See Chart Below:
Swiss Re AG – ADR has a price-earnings of 8 with a 52 week low of $20.10 and a 52 week high of $25.10. Swiss Re AG – ADR’s market capitalization is currently $0.0.
General Company Details For Swiss Re AG – ADR (NASDAQ:SSREY)
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company’s clients include insurance companies, mid- to large-sized corporations and public sector clients. Its segments include Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Admin Re. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments. The Corporate Solutions segment is engaged in serving mid-sized and large corporations, with product offerings ranging from traditional property and casualty insurance to customized solutions. The Admin Re segment provides risk and capital management solutions by which the Company acquires closed books of in-force life and health insurance business, entire lines of business, or the entire capital stock of life insurance companies. The Company’s open and closed life insurance books, including Admin Re, and are managed under a unit called Life Capital.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.